Financial Times: Johnson & Johnson Considers Acquiring Ollin Biosciences for Up to $3.4 Billion
According to the Financial Times, Johnson & Johnson is considering acquiring Ollin Biosciences, a biotechnology company specializing in ophthalmic research and development, for up to $3.4 billion. Existing headlines and summaries describe it as a potential acquisition, indicating that the deal has not yet been signed or completed, and no specific payment structure has been provided.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
ZEC (Zcash) surged 6.23% in a short-term rally over the past 4 hours, currently trading at $878.990
-
2
XRP surged 6.54% in a 4-hour window, currently trading at $0.9548
-
3
HYPE (Hyperliquid) is up 6.19% in the past hour, currently trading at $66.580
-
4
ZEC (Zcash) surged 9.65% in a 1-hour short-term rally, currently trading at $928.310
-
5
ETH (Ethereum) surged 5.32% within 1 hour, currently trading at $1,809.73
-
6
NEAR (NEAR Protocol) is up 6.33% in the past 4 hours, currently trading at $3.139
-
7
SOL (Solana) surged 6.36% in a short-term rally over the past hour, currently trading at $71.930
-
8
What is NPEPE coin? Where to buy and trade NPEPE coin?
-
9
South China Morning Post: UBS unveils new Hong Kong West Kowloon headquarters, with around 3,500 employees planned to move in starting in the fourth quarter
-
10
The Korea Herald: HD Hyundai and Anduril Launch First Jointly Developed 600-Ton Class Autonomous Surface Vessel
Markets Today
Recommended Reading


